Establishment Labs Holdings Inc

Aktienanalyse zu Establishment Labs Holdings Inc (ESTA)

$59.180

-2.101 (-3.55%)Zum Schluss

Loading chart…
Hoch
62.312
Eröffnung
61.650
Volumengewichteter Durchschnittskurs
60.09
Volumen
293.83K
Marktkap.
1.21B
Tief
58.780
Umsatz
17.66M
EV/EBITDA, TTM
-186.06

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

KI-Analyse of Establishment Labs Holdings Inc (ESTA)

Halten

Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.

Analystenbewertungen (3)

+40.05% Aufwärtspotenzial
Kaufen
3 Kaufen
0 Halten
0 Verkaufen
Aktuell: 59.18
Tief
75.00
Durchschnitt
82.88
Hoch
90.00

Citi

2026-08-13

Kursziel

$92

Kaufen

Canaccord

2026-08-07

Kursziel

$105

Kaufen

Mizuho

2026-07-15

Kursziel

$105

Überdurchschnittlich

Citi

2026-07-08

Kursziel

$92

Neutral

BTIG

2026-05-07

Kursziel

$90

Kaufen

Bewertungskennzahlen

Das aktuelle erwartete KGV von Establishment Labs Holdings Inc (ESTA) beträgt 204.08, verglichen mit dem 5-Jahres-Durchschnitt von -20.44.

Erwartetes KGV

Stark überbewertet
5J-Durchschnitt P/E
-20.44
Aktuelles P/E
204.08
Überbewertet
21.84
Unterbewertet
-62.73

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
-84.15
Aktuelles EV/EBITDA
-186.06
Überbewertet
41.92
Unterbewertet
-210.22

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
7.01
Aktuelles P/S
5.39
Überbewertet
8.83
Unterbewertet
5.19

Alphio-AI-Kursszenarien für ESTA

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%ESTA

$56.20

Szenariopreis

B

Basis

Basis · 50%ESTA

$47.64

Szenariopreis

B

Bärisch

Bärisch · 25%ESTA

$46.67

Szenariopreis

Whales, die ESTA halten

R

Rice Hall James & Associates, LLC

+ HältESTA

-0.61%

3-Monats-Rendite

Q

Qatar Holding LLC

+ HältESTA

-6.20%

3-Monats-Rendite

S

Summit Partners Public Asset Management, LLC

+ HältESTA

-7.12%

3-Monats-Rendite

B

Boothbay Fund Management, LLC

+ HältESTA

-9.47%

3-Monats-Rendite

R

RTW Investments, LP

+ HältESTA

-11.31%

3-Monats-Rendite

A

ADAR1 Capital Management, LLC

+ HältESTA

-16.51%

3-Monats-Rendite

Event-Zeitleiste

2026-09-21 (ET)

08:31:00

Establishment Labs Presents New Data on Breast Tissue Preservation

2026-06-29 (ET)

08:30:00

Establishment Labs Appoints Taylor Harris to Board of Directors

2026-05-06 (ET)

08:10:00

Company Expects Minimally Invasive Business to Exceed $35M in 2026

08:10:00

Company Reports Q1 Revenue of $59.9M, Exceeding Expectations

2026-04-30 (ET)

09:00:00

Establishment Labs Secures $300M Loan Facility

News

ESTA FAQ – beantwortet von Alphio AI

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.

3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln